98%
921
2 minutes
20
Background: Obstructive sleep apnea (OSA), characterized by chronic intermittent hypoxia (CIH), has been implicated in the development and progression of non-alcoholic fatty liver disease (NAFLD). The importance of macrophages in NAFLD pathogenesis has been well-documented, yet the impact of CIH on liver macrophages and the underlying mechanisms during NAFLD progression remain largely unclear.
Methods: In this study, we established two types of NAFLD murine models and simultaneously exposed the mice to CIH or room air condition to evaluate the impact of CIH on hepatic pathophysiology and liver macrophage status. In vitro experiments utilizing bone marrow-derived macrophages (BMDMs) were conducted to validate the CIH-induced macrophage polarization and its contribution to hepatocyte injury. Furthermore, the role of secreted phosphoprotein 1 (SPP1) in CIH-mediated macrophage polarization was investigated.
Results: CIH exposure significantly exacerbated liver injury in both high-fat diet and methionine-choline-deficient diet induced NAFLD models, as indicated by increased hepatic inflammation and fibrosis. Further liver macrophage analysis revealed a marked increase in macrophage accumulation and a significant shift toward M1 polarization under CIH conditions during NAFLD progression. Similarly, CIH-exposed BMDMs demonstrated pronounced M1 polarization and pro-inflammatory activation, which aggravated lipid-induced hepatocyte injury. Transcriptomic analysis identified consistent upregulation of Spp1 in both CIH-exposed BMDMs and liver macrophages from NAFLD murine models. Elevated SPP1 expression was also confirmed in CIH-exposed macrophages and NAFLD liver tissues. Functional validation studies revealed that SPP1 knockdown in macrophages effectively attenuated CIH-induced M1 polarization and reduced associated inflammatory and fibrotic injury in hepatocytes.
Conclusion: CIH promotes inflammatory polarization of liver macrophages through the upregulation of SPP1, thereby exacerbating hepatocyte injury and accelerating the progression of NAFLD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.freeradbiomed.2025.06.050 | DOI Listing |
J Nutr Biochem
September 2025
Department of Woman-Mother-Child, Division of Pediatrics, DOHaD Laboratory, University of Lausanne and Lausanne University Hospital, 1011 Lausanne, Switzerland. Electronic address:
Background: Individuals born after intrauterine growth restriction (IUGR) have a higher risk of developing metabolic syndrome (MetS) in adulthood. In a rat model, male IUGR offspring exhibit MetS features-including elevated systolic blood pressure, glucose intolerance, non-alcoholic fatty liver disease, and increased visceral adipose tissue (VAT)-by 6 months of age. Female offspring, however, do not.
View Article and Find Full Text PDFWorld J Gastroenterol
August 2025
Department of General Surgery, Wujin Hospital Affiliated with Jiangsu University, Changzhou 213162, Jiangsu Province, China.
Background: The progression of non-alcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis (NASH) and liver fibrosis remains poorly understood, though liver sinusoidal endothelial cells (LSECs) are thought to play a central role in disease pathogenesis.
Aim: To investigate the role of in NAFLD fibrosis through its regulation of LSEC dysfunction and macrophage polarization.
Methods: We analysed single-cell transcriptomic data (GSE129516) from NASH and normal mouse models and identified as a key regulator in LSECs.
Nat Immunol
September 2025
Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Immune cells play a central yet poorly understood role in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis (MASLD/MASH), a global cause of liver disease with limited treatment. Limited access to human livers and lack of studies across MASLD/MASH stages thwart identification of stage-specific immunological targets. Here we provide a unique single-cell RNA sequencing atlas of paired peripheral blood and liver fine-needle aspirates from a full-spectrum MASLD/MASH human cohort.
View Article and Find Full Text PDFInt J Mol Sci
August 2025
Department of Pathology and Laboratory Medicine, University of Alberta, Edmonton, AB T6G 1B7, Canada.
Liver sinusoidal endothelial cells (LSECs) are essential for preserving liver homeostasis. Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a category of hepatic disorders characterized by excessive fat accumulation in the liver, known as steatosis. Over time, accumulated hepatic fat can induce inflammation of the liver (hepatitis).
View Article and Find Full Text PDFMetabolites
August 2025
Grupo de Investigación en Enfermedades Cardiorrenales y Metabólicas, Departamento de Medicina y Cirugía, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera-CEU, CEU Universities, C/Santiago Ramón y Cajal s/n, 46115 Valencia, Spain.
: Sodium-glucose cotransporter-2 inhibitors (SGLT2is), initially developed as antihyperglycemic agents, have emerged as multifunctional therapeutics with profound cardiorenal and metabolic benefits. Their unique insulin-independent mechanism, targeting renal glucose reabsorption, distinguishes them from conventional antidiabetic drugs. : SGLT2is induce glycosuria, reduce hyperglycemia, and promote weight loss through increased caloric excretion.
View Article and Find Full Text PDF